Benefits
Supports low back comfort
Standardized willow bark extracts providing 240 mg of salicin daily have been shown in randomized trials to support reductions in low back pain compared with placebo, with effects building over several weeks of consistent use.
May ease osteoarthritis-related discomfort
Randomized trials of standardized willow bark extract have shown moderate analgesic effects in adults with osteoarthritis, supporting its traditional use as a botanical aid for joint discomfort in selected adults.
Multi-component anti-inflammatory profile
Beyond salicin-derived salicylic acid, willow bark provides flavonoids and polyphenols that may contribute additional anti-inflammatory and antioxidant activity, supporting a broader pharmacological footprint than salicin alone.
Traditional botanical analgesic
Willow bark has centuries of traditional use as an analgesic and was the historical precursor to modern aspirin, providing a recognizable botanical option for adults exploring plant-derived approaches to occasional pain.
Once- to twice-daily standardized dosing
Standardized willow bark extracts allow consistent salicin delivery across the day with simple dosing schedules, supporting practical use over short courses of several weeks in adults with low back or joint discomfort.
Mechanism of action
Salicin to salicylic acid conversion
Gut bacteria hydrolyze salicin to saligenin, which is absorbed and oxidized in the liver to salicylic acid, the same active metabolite as that produced from acetylsalicylic acid (aspirin), responsible for much of the analgesic and anti-inflammatory effect.
Cyclooxygenase pathway modulation
Salicylic acid and willow bark constituents can inhibit cyclooxygenase enzymes and reduce prostaglandin synthesis in inflammatory cells, contributing to reductions in pain signaling and inflammatory mediator output.
Polyphenol and flavonoid activity
Willow bark flavonoids and polyphenols show antioxidant and anti-inflammatory activity in laboratory studies, which may contribute additional support beyond what is attributable to salicin alone.
Slower, more prolonged salicylate exposure
Salicin is gradually converted to salicylic acid via gut and hepatic metabolism, producing lower peak but more prolonged salicylate levels than equivalent doses of acetylsalicylic acid, which may influence its analgesic profile and tolerability.
Clinical trials
Randomized, double-blind, placebo-controlled trial; 4 weeks; willow bark extract providing 120 or 240 mg salicin daily vs placebo.
210 adults with low back pain exacerbations.
The 240 mg salicin group showed significantly higher rates of pain-free status without rescue medication than placebo, with intermediate benefit at 120 mg, supporting a dose-response effect of standardized willow bark on acute low back pain.
Randomized, double-blind, placebo-controlled trial; 2 weeks; standardized willow bark extract providing 240 mg salicin daily.
78 adults with osteoarthritis of hip or knee.
Willow bark extract produced a moderate analgesic effect in osteoarthritis pain compared with placebo, with generally good tolerability over the 2-week intervention period.
Systematic review of randomized clinical trials of Salix-based preparations across musculoskeletal pain conditions.
Adults with low back pain, osteoarthritis, or other musculoskeletal pain syndromes.
Reviewers concluded there is moderate evidence supporting ethanolic willow bark extract for low back pain, mixed evidence for osteoarthritis, and insufficient data for rheumatoid arthritis, with overall safety comparable to short courses of conventional analgesics in adults.